ULB Hopital Erasme Trials

ULB Hopital Erasme	Welcome, Profile Billing Logout

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Laethem, Jean-Luc Van

PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel

Completed

571

Europe, Canada, US, RoW

NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel

NovoCure Ltd.

Pancreas Adenocarcinoma

10/24

REGINA, NCT04503694 / 2020-000876-40: Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

Recruiting

Europe

Nivolumab 10 MG/ML Intravenous Solution, Regorafenib 30 MG Oral Tablet, Radiotherapy, Surgery, Non-operative Management

Jules Bordet Institute

Rectal Cancer Stage II, Rectal Cancer Stage III

01/26

12/30

NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting

134

Europe

Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin

Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Metastatic Pancreatic Ductal Adenocarcinoma

12/26

12/27

STEREOPAC, NCT05083247: Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Recruiting

256

Europe

mFOLFIRINOX or Gemcitabine nab-paclitaxel, mFFX or Gem/Nab-p, Isotoxic High-Dose (iHD)-SBRT, Surgery

Erasme University Hospital, Jules Bordet Institute, Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Pancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma

12/27

12/30

R-IMMUNE, NCT03127007 / 2016-004526-41: Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer

Active, not recruiting

1/2

Europe

Atezolizumab, Tecentriq, MPDL3280a, 5-FU based radio-chemotherapy

Grand Hôpital de Charleroi, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Rectal Neoplasms

02/24

09/24

OPTIMIZE-1, NCT04888312 / 2020-005182-14: Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients

Active, not recruiting

1/2

Europe

CD40 agonist mitazalimab in combination with chemotherapy, ADC-1013, JNJ-64457107

Alligator Bioscience AB, Theradex, BC Platforms

Metastatic Pancreatic Ductal Adenocarcinoma

01/24

06/26

Huberty, Vincent

NCT03999502: Endomina Suturing Device as a Treatment of GERD.

Recruiting

N/A

Europe

Endomina

Erasme University Hospital

GERD

05/21

05/22

EPSILON, NCT04977401: EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection

Terminated

N/A

Europe, Japan

Endoscopic submucosal dissection, use of Orise Gel as lifting agent for endoscopic submucosal dissection, use of glycerol as lifting agent for endoscopic submucosal dissection

Erasme University Hospital

Early Gastric Cancer, Rectal Polyp

12/22

01/23

NCT02046590: RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP

Terminated

N/A

120

Europe

Propofol, General anesthesia

Erasme University Hospital

Anesthesia, ERCP, Safety, Efficacy

02/23

NCT02244164: Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Terminated

N/A

Europe

Incretinomimetics, - exenatide (Byetta®), - liraglutide (Victoza®), - lixisenatide (Lyxumia®), - exenatide extended-release (Bydureon®)., DPP-4 inhibitors, - sitagliptine (Januvia®), - vildagliptine (Galvus®), - saxagliptine (Onglyza®), - linagliptine (Trajenta®).

Erasme University Hospital

Type 2 Diabetes, Incretinomimetics, Pancreas

02/23

NEX-ENDOHS, NCT06096948: Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection

Recruiting

N/A

Europe

NEXPOWDER-ENDOHS

Erasme University Hospital

Gastro Intestinal Bleeding, Polyps

04/24

07/24

Creteur, Jacques

c-easie, NCT04747795: Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments

Completed

301

Europe

Vitamin C, Ascorbic Acid, Normal saline, physiological serum, placebo

Universitaire Ziekenhuizen KU Leuven, Federaal Kenniscentrum voor Gezondheidszorg, Belgium

Sepsis, Septic Shock, Sepsis, Severe

08/23

11/23

Marmol, VÃ©ronique del

No trials found

Trial + Data / Events

Status

Region

Interventions

Sponsor

Conditions

Primary compl

Study compl

Laethem, Jean-Luc Van

PANOVA-3, NCT03377491: Effect of Tumor Treating Fields (TTFields, 150 kHz) as Front-Line Treatment of Locally-advanced Pancreatic Adenocarcinoma Concomitant With Gemcitabine and Nab-paclitaxel

Completed

571

Europe, Canada, US, RoW

NovoTTF-200T, TTFields, Gemcitabine, nab paclitaxel

NovoCure Ltd.

Pancreas Adenocarcinoma

10/24

REGINA, NCT04503694 / 2020-000876-40: Neoadjuvant Regorafenib in Combination with Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer

Recruiting

Europe

Nivolumab 10 MG/ML Intravenous Solution, Regorafenib 30 MG Oral Tablet, Radiotherapy, Surgery, Non-operative Management

Jules Bordet Institute

Rectal Cancer Stage II, Rectal Cancer Stage III

01/26

12/30

NALPAC, NCT05472259 / 2020-003889-39: A Study Evaluating the Efficacy of 5-FU + NALIRI and 5-FU + NALIRINOX for PDAC

Recruiting

134

Europe

Nanoliposomal irinotecan, Onyvide, 5 FU, Fluorouracil, Leucovorin, Folinate, Elvorine, Oxaliplatin

Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Metastatic Pancreatic Ductal Adenocarcinoma

12/26

12/27

STEREOPAC, NCT05083247: Preoperative mFOLFIRINOX (or Gem-Nab-P) +/- Isotoxic High-dose SBRT for Borderline Resectable Pancreatic Adenocarcinoma

Recruiting

256

Europe

mFOLFIRINOX or Gemcitabine nab-paclitaxel, mFFX or Gem/Nab-p, Isotoxic High-Dose (iHD)-SBRT, Surgery

Erasme University Hospital, Jules Bordet Institute, Belgian Group of Digestive Oncology, University Hospital St Luc, Brussels

Pancreatic Neoplasm, Pancreatic Adenocarcinoma, Borderline Resectable Pancreatic Adenocarcinoma

12/27

12/30

R-IMMUNE, NCT03127007 / 2016-004526-41: Safety and Efficacy of Atezolizumab Combined to Preoperative Radio-chemotherapy in Localized Rectal Cancer

Active, not recruiting

1/2

Europe

Atezolizumab, Tecentriq, MPDL3280a, 5-FU based radio-chemotherapy

Grand Hôpital de Charleroi, Cliniques universitaires Saint-Luc- Université Catholique de Louvain

Rectal Neoplasms

02/24

09/24

OPTIMIZE-1, NCT04888312 / 2020-005182-14: Safety and Efficacy of Mitazalimab in Combination with Chemotherapy in Pancreatic Cancer Patients

Active, not recruiting

1/2

Europe

CD40 agonist mitazalimab in combination with chemotherapy, ADC-1013, JNJ-64457107

Alligator Bioscience AB, Theradex, BC Platforms

Metastatic Pancreatic Ductal Adenocarcinoma

01/24

06/26

Huberty, Vincent

NCT03999502: Endomina Suturing Device as a Treatment of GERD.

Recruiting

N/A

Europe

Endomina

Erasme University Hospital

GERD

05/21

05/22

EPSILON, NCT04977401: EndoscoPic Submucosal dIssection Using geL Versus glycerOl for Submucosal iNjection

Terminated

N/A

Europe, Japan

Endoscopic submucosal dissection, use of Orise Gel as lifting agent for endoscopic submucosal dissection, use of glycerol as lifting agent for endoscopic submucosal dissection

Erasme University Hospital

Early Gastric Cancer, Rectal Polyp

12/22

01/23

NCT02046590: RCT of Efficacy and Safety of Sedation Compared to General Anesthesia for ERCP

Terminated

N/A

120

Europe

Propofol, General anesthesia

Erasme University Hospital

Anesthesia, ERCP, Safety, Efficacy

02/23

NCT02244164: Pathophysiological Study of the Increase in Pancreatic Volume in Type 2 Diabetes Treatments.

Terminated

N/A

Europe

Erasme University Hospital

Type 2 Diabetes, Incretinomimetics, Pancreas

02/23

NEX-ENDOHS, NCT06096948: Nexpowder to Prevent Delayed Bleeding After Endoscopic Resection

Recruiting

N/A

Europe

NEXPOWDER-ENDOHS

Erasme University Hospital

Gastro Intestinal Bleeding, Polyps

04/24

07/24

Creteur, Jacques

c-easie, NCT04747795: Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments

Completed

301

Europe

Vitamin C, Ascorbic Acid, Normal saline, physiological serum, placebo

Universitaire Ziekenhuizen KU Leuven, Federaal Kenniscentrum voor Gezondheidszorg, Belgium

Sepsis, Septic Shock, Sepsis, Severe

08/23

11/23

No trials found



	Diseases Companies Products Productz Mechanisms of Action Sites